News
Zacks Small Cap Research on MSN32m
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 results in a May 13th press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback